Science ❯ Biotechnology

Vaccine Research

Clinical Trials Infectious Diseases mRNA Technology mRNA Research Immunology Preclinical Studies Adjuvant Mechanisms mRNA Vaccines Animal Vaccines Clinical Research

Lilly Agrees to Buy Three Vaccine Developers for Up to $3.8 Billion

The purchases mark a strategic shift into vaccine-led prevention that Lilly says will move forward only after routine regulatory clearances.

Colombia Signs Deal With SK Bioscience to Build Domestic Vaccine Production

Biovac Opens Cape Town Product Development Lab to Advance Africa’s Vaccine Capacity

Moderna Opens UK’s First Onshore mRNA Vaccine Plant at Harwell

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

HHS Pulls Funding From 22 mRNA Vaccine Programs

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

Dual-Adjuvant HIV Vaccine Elicits Robust Single-Dose Immunity in Mice

WHO Launches Initiative to Develop mRNA Vaccines for H5N1 Bird Flu